Hence, inhibitors specific for Bcl‐2 or Mcl‐1 have been developed as direct inducers for tumor cell apoptosis in chronic lymphocytic leukemia and small lymphocytic lymphoma, and hamper tumor progression both in patients and in tumor mouse models.77 The gene discussed is BCL2; the disease is B-cell chronic lymphocytic leukemia.